On September 27, a 17-year-old boy in Canada died of a heart attack at home, reportedly two weeks after receiving a COVID vaccine mandated by hockey arena.

Sean Hartman is said to have developed “multiple” health problems “immediately” after receiving the vaccine, including myocarditis, or heart inflammation. He got the COVID shot so he could play hockey in an arena where the shot is required for entry.

A small protest was held near the hockey arena that required the jab. One participant held a sign facing the road that read:

“A broken heart from not being allowed to play hockey will heal. Myocarditis from the jab will kill (or be a long-long condition).”

“He was not allowed to play hockey in the arena because they’d asked him [to] take the jab. And they said to him ‘you’re not allowed in the arena’ (inaudible). He got the jab and now two weeks later he’d been sick, he died yesterday,” the man said in a video shared by The Covid World.

Another sign displayed at the protest read “Kids are dying from the jab.” 

Tributes to Sean Hartman

GoFundMe page created by Paul Blair, his “best friend since the first grade” wrote that for all of Sean’s life “there was nothing that Sean was more passionate about than sports, especially hockey, as he played his entire life. He started his hockey career playing for the Beeton Stingers and went on to play for TNT in Alliston. Whether watch or play, Sean just loved the game.”  

The Beaton Athletic Association shared on Facebook, “Sean started his hockey career here in Beeton when he was 5 years old. At  11 years old, he played for TNT Tornadoes for 3 years. He returned to his hometown of Beeton in his major Bantam year and has been a member of our association ever since.”

“A solid defenseman. Always supportive of his goalie and teammates. Coachable in every aspect of the game, on and off the ice. He will be fondly remembered by our whole Beeton Athletic Association, board members, coaches and teammates and friends.”

Public Health Ontario released a report covering jab data from December 2020 to August 7, 2021, and concluded the “highest reporting rate of myocarditis/pericarditis was observed in males age 18-24 years following second dose.”

Covid vaccine for the young

Sweden and Denmark have recently halted the use of Moderna’s COVID vaccine for younger age groups, citing an increase in myocarditis and pericarditis among vaccinated youths and young adults.

Pfizer has also added a warning to its COVID-19 jab fact sheet concerning myocarditis and pericarditis. 

Canadian professor of medicine Dr. Steven Pelech has maintained that “Contrary to what a number of people have said, there is no such thing as ‘mild myocarditis.’”

He has noted that when the heart cells die from myocarditis “they are not replaced in your body and are instead replaced by scar tissue, which is from fibroblasts.”

“The remaining muscle cells have to get a little bigger in order to compensate. Every time you get an inflammatory response, you lose more of that contractility and have a greater chance of heart attack and other problems later in life,” Pelech explained.

U.S. researchers have found that boys age 12 to 15 “with no underlying medical conditions, are four to six times more likely to be diagnosed with vaccine-related myocarditis than ending up in hospital with Covid over a four-month period.”

(Source: Life Site News)

COVID-19 vaccine: Are boys at an increased risk of heart inflammation?

A non-peer-reviewed retrospective paper, released as a pre-print, analyzed the rate of post-vaccination cardiac myocarditis in children aged 12–15 and 16–17 years who had received mRNA COVID-19 vaccines.

The researchers did so by searching the Vaccine Adverse Event Reporting System (VAERS) for reports of children aged 12-17 years from January 1, 2021, to June 18, 2021. They searched using the words myocarditis, pericarditis, myopericarditis, chest pain, and a troponin lab, which identifies a heart attack and other heart conditions.

The study identified 257 CAEs in total and reported rates (in cases per million after the second dose) of 162.2 in boys aged 12–15 years, 94 in boys aged 16–17 years, 13 in girls aged 12-15 years, and 13.4 in girls aged 16–17 years.

The study estimated that CAE incidence was between 3.7 and 6.1 times higher than their 120-day COVID-19 hospitalization risk (August 21, 2021) in healthy boys aged 12–15 receiving their second mRNA dose. They estimated that the CAE incidence was 2.1–3.5 times higher in healthy boys aged 16–17.

The paper appears on the pre-print server MedRxiv.

Heart problems in vaccinated students trigger scrutiny of campus COVID mandates

“Even a slight risk of a serious vaccine adverse reaction could tip the benefit-risk calculation” for young people, medical professors say.